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Shock Wave Therapy Improves Cartilage & Subchondral Bone 
Repair
M.B. Hurtig1, R.M. Streicher2;
1Clinical Studies, University of Guelph, Guelph, Canada, 
2Orthopaedics, Stryker SA, Thalwil, Switzerland
Purpose: To determine if extracorporeal shock wave therapy (SWT) 
improves cartilage healing in an osteochondral defect rabbit model. 
Methods and Materials: Two 3 mm diameter patellofemoral 
osteochondral defects were made bilaterally in 48 radult rabbits. 
Animals were assigned to groups: no treatment (NT), unilateral SWT-
500 pulses and SWT-1500 pulses. SWT was administered immediately 
QPTUPQFSBUJWFMZ JO  BOJNBMT BOE UIFZXFSF TBDSJ¾DFEPOEBZT
(n=3), 30 (n=15), and 90 (n=15). The remaining 15 rabbits received 
BOBEEJUJPOBM485USFBUNFOUPOEBZBOEXFSFTBDSJ¾DFEPOEBZ
300. Outcome measures reported here include ICRS histological 
scoring, type II collagen immunostaining, creep indentation and 
biochemistry (sGAG) of cartilage as well as microCT. 
Results: At 30 days matrix and cell type were improved in the 
SWT-1500 group and surface continuity was improved in the SWT-
500 over NT controls (p=.05, Wilcoxon). By day 90 the SWT-1500 
group had improved cell type (p=.06) and the SWT-500 group had 
improved cartilage sGAG (p=.05), cell viability, subchondral bone 
integrity (both p=.01), and subchondral bone mineral conentration 
(p=.05) . Cartilage healing was ongoing in the long term rabbits, but 
the SWT-500 group had better cell distribution and type, cell viability 
	Q
 DBMDJ¾FE DBSUJMBHF SFTUPSBUJPO 	Q 
 BOE TVCDIPOESBM
bone mineral concentration (p=.01). 
Conclusions: SWT has a dose dependant effect on cartilage repair 
and subchondral bone mineralization but additional investigations 
TIPVMECFEPOFUPPQUJNJ[FUJNJOHOVNCFSPGUSFBUNFOUTBOE¾OBM
outcome.
P158
Long-term evaluation of the resurfacing of large cartilage defects 
by a periosteal cell-based approach supported by BMP-2 gene 
transfer
K. Gelse1, O. Franke2, J. Park3, C. Mühle4, K. von der Mark3, F. Hennig5,
B. Swoboda6, H. Schneider7;
1Department Of Trauma Surgery, University Hospital Erlangen, 
Germany, Erlangen, Germany, 2Materials Science And Engineering, 
University Erlangen, Erlangen, Germany, 3Experimental Medicine I, 
University Erlangen, Erlangen, Germany, 4Department Of Pediatrics, 
Experimental Neonatology, Medical University Innsbruck, 
Innsbruck, Austria, 5Department Of Trauma Surgery, University 
Hospital, Erlangen, Germany, 6Orthopaedic Rheumatology, 
University Erlangen, Erlangen, Germany, 7Department Od Pediatrics, 
Experimental Neonatology, Medical University of Innsbruck, 
Innsbruck, Austria
Purpose: To investigate the potential of transgene-activated periosteal 
cells for resurfacing large partial-thickness cartilage defects. 
Methods and Materials: In miniature pigs, bone morphogenetic 
protein-2 (BMP-2) gene transfer using a combination of adeno-
associated (AAV) and adenoviral (Ad) vectors was performed to 
stimulate autologous periosteal cells prior to loading the cells on 
a polyglycolic acid scaffold and application to chondral lesions 
comprising the entire medial half of the patella. The resulting 
repair tissue was analysed 6 and 26 weeks after transplantation by 
histochemical and immunohistochemical methods. The biomechanical 
properties of the repair tissue were characterized by nanoindentation 
measurements. Implants of unstimulated cells and untreated lesions 
served as controls. 
Results: Six weeks after transplantation all grafts showed tight 
integration into the pre-existing cartilage. BMP-2-stimulated 
periosteal cells had adopted a chondrocyte-like phenotype in all 
layers. The newly formed repair tissue was rich in proteoglycans 
and type II collagen, and its contact stiffness was close to that of 
healthy hyaline cartilage. Unstimulated periosteal cells only formed 
¾CSPDBSUJMBHJOPVT SFQBJS UJTTVF XJUI B SFEVDFE DPOUBDU TUJGGOFTT
However, 26 weeks following transplantation the AAV/Ad-stimulated 
DFMMT JOTVQFS¾DJBM MBZFST UFOEFE UPEFEJGGFSFOUJBUF JOUP¾CSPCMBTUJD
cells characterized by a switch from type II to type I collagen synthesis 
and reduced contact stiffness. In deeper zones, however, the cells 
retained their chondrocytic phenotype with type II collagen staining 
of the matrix. 
Conclusions: Large partial-thickness cartilage defects can be 
resurfaced with hyaline-like cartilage formed by transgene-activated 
periosteal cells. Its long-term stability seems to depend on physico-
biochemical factors provided only in deeper zones of cartilaginous 
tissue. 
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A pilot study of tacrolimus (FK506) for cartilage repair
F. Nishigaki1, M.B. Hurtig2, Y. Shimizu1, H. Murai1, N. Takeshita1,
Y. Ohkubo1, S. Mutoh1;
1Pharmacology Research Laboratories, Astellas Pharma. Inc., Osaka, 
Japan, 2Clinical Studies, University of Guelph, Guelph, Canada
Purpose: Tacrolimus is an immunosuppressant that can create 
chondroid differentiation in vitro and suppress collagen-induced 
arthritis in rats. Our hypothesis was that tacrolimus would improve 
the cartilaginous phenotype of repair tissue in acute chondral 
defects. 
Methods and Materials: Full thickness, microfractured chondral 
defects (8mm) were made bilaterally in the trochlear ridge of 18 
adult sheep.Three treatment groups were: no treatment (n=4), 0.03 
mg/kg (n=7) and 0.1 mg/kg (n=7). Treated joints received intra-
articular injections of FK506 every 14 days while the contralateral 
joints received 0.5% methylcellulose. Three animals in each 
USFBUNFOUHSPVQXFSFTBDSJ¾DFEBUEBZTBOEUIFSFNBJOJOHTIFFQ
XFSF TBDSJ¾DFE BU  EBZT QPTUPQFSBUJWFMZ 4ZOPWJBM ¿VJE ',
DPODFOUSBUJPOTXFSFNFBTVSFEUPDPO¾SNEFMJWFSZ*OEJBJOLTUBJOJOH
O’Driscoll histology scoring, histomorphometry, sGAG concentration, 
and immunostaining for type II collagen were performed. 
Results: At 90 days there was a trend for improved histology scores 
	WFSTVTPVUPG
BOET("(DPODFOUSBUJPO	Q<.06, T-
test) in joints treated with 0.1 mg/kg. At the 180 day endpoint there 
were improved histological scores for the 0.03 mg/kg group over 
the no treatment group and contralateral joints (p<
5JTTVF¾MM
saffranin-O stained volume and collagen II immunostaining within 
the experimental defects was improved in the 0.03 mg/kg group over 
controls but the small group size eliminated statistical differences. 
Though chondral healing was improved it was incomplete in this 
challenging model. 
Conclusions: This small pilot study indicates that FK506 can 
QPTJUJWFMZJO¿VFODFDBSUJMBHFSFQBJSJONJDSPGSBDUVSFEGVMMUIJDLOFTT
lesions. Additional studies may help identify an optimized timeframe 
and dosing regime. 
P160
Occurrence and patterns of meniscus damage following ACL 
transection
E. Lindhorst1, N. Kimmig2, F. Hentschel2, A. Theisen3, T. Aigner4,
L. Wachsmuth5;
1Surgery, University of Marburg, Eppstein, Germany, 2Surgery,
University of Frankfurt, Frankfurt/Main, Germany, 3Central Research 
Unit, University of Frankfurt, Frankfurt/Main, Germany, 4Pathology,
University of Leipzig, Leipzig, Germany, 5Medical Physics, University 
of Erlangen, Erlangen, Germany
Purpose: Evaluation of the frequency and pattern of meniscus 
damage following anterior cruciate ligament (ACL) transection 
Methods and Materials: 32 NZW rabbits were used according to a 
protocol permitted by both, the Institutional and the Governmental 
Ethics Committee. All animals were male and skeletally mature as 
checked by standard x-ray. An open medial parapatellar approach 
was used of only the right knees. A complete transection of the ACL 
was achieved under full visualisation of the ligament. Postoperatively, 
rabbits were allowed full activity in their cages. At 2, 4, 8 and 12 
XFFLTSBCCJUTFBDIXFSFTBDSJ¾DFE"UEJTTFDUJPOUIFGSFRVFODZ
and pattern of meniscus damage was recorded for both, medial and 
lateral menisci. 
Results: The frequency of changes was 5/8 in the right knees at 2 
weeks, 6/8 at 4 weeks, 7/8 at 8 weeks and 6/8 at 12 weeks. At 2 
XFFLTEBNBHFTMJLFNFOJTDVTPFEFNB¾CSJMMBUJPOTBOENJOPSUFBST
of the posterior horn were observed. The tear sizes grew with time, 
BMTPNBKPS¾CSJMMBUJPOTBOENFOJTDVTEJTMPDBUJPOTPDDVSSFE"UBOE
12 weeks, damage to medial and lateral menisci was observed in the 
majority of knee joints. 
Conclusions: Transection of the ACL leads to meniscus damage in 
rabbits, like after ACL rupture in human patients. Under full weight 
bearing, this meniscus damage begins very early. It seems to follow a 
UZQJDBMQBUUFSOPGJODSFBTJOHOVNCFSBOETJ[FXJUIUJNF0VS¾OEJOHT
underline that damage secondary to ACL rupture is not restricted to 
just one (medial) compartment but is a secondary joint disease. 
